Business Standard

Lanxess India inks pact to upgrade civil hospital's facilities in Nagda

As per the three-year agreement, the German specialty chemicals firm will contribute towards the upgradation of the existing facilities of the hospital

Lanxess India's Nagda plant in Madhya Pradesh

Lanxess India's Nagda plant in Madhya Pradesh

BS B2B Bureau Mumbai
As part of its corporate social responsibility (CSR) initiatives, the Indian arm of German specialty chemicals company Lanxess has signed a three year long agreement with Civil Hospital, Nagda (Madhya Pradesh), wherein, the organisation will contribute towards the upgradation of the existing facilities and infrastructure of the hospital. In the current year, Lanxess India will donate a state-of-the-art dialysis machine to the hospital. 

Having already donated a digital X-ray machine to the civil hospital last year, Lanxess identified a still existent gap in the medical facilities available to the locals vis-a-vis demand. The idea was to lessen the dependability of the locals on medical establishments based in far-off cities like Ujjain & Indore. Setting up of the dialysis machine in the Nagda Civil Hospital will ensure timely treatment at affordable costs for the local patients thereby, improving the quality of medical aid in the region.
 
In the following years, Lanxess India will contribute towards aiding the civil hospital with need based medical equipment and facilities in due consultation with the hospital authorities and local administration. The hospital has undertaken the responsibility to operate and maintain the dialysis machine.

“At Lanxess, we have always endeavoured to contribute positively to the lives of the people in Nagda and would continue to do so. We have been constantly expanding our community outreach programmes and this is one such step towards improving the quality of life of the people in the area,” stated Neelanjan Banerjee, senior executive director, Lanxess India.

Lanxess is a leading specialty chemicals company with sales of Euro 7.9 billion in 2015 and about 16,700 employees in 29 countries. The company is currently represented at 55 production sites worldwide. The core business of Lanxess is the development, manufacturing and marketing of chemical intermediates, specialty chemicals and plastics.

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 24 2016 | 3:12 PM IST

Explore News